

Ask three clinics what hormone pellet therapy costs and you will get three answers, none of them comparable. One quotes a single insertion, one quotes a year, one quotes a membership that bundles labs. None of that is dishonest, it is just that pellet therapy is not one purchase. It is a recurring procedure with testing attached, and the annual figure is the only one that means anything.
This article explains what the price is actually made of, why insurance usually will not help, and what the major medical societies say about compounded pellets, because that affects both the cost and the decision. We have deliberately not published a dollar figure here. Dosing is individual, pellet pricing is dose dependent, and a number on a blog post would be a number you could not hold anyone to.
Pellet therapy has at least six cost components, and which ones apply depends on you. Our hormone replacement page sets out the program structure; the table below sets out what you are paying for inside it.
| Cost component | What determines it |
|---|---|
| Initial consultation and evaluation | A physician visit, history and symptom assessment. Sometimes covered by insurance as an office visit even when the therapy is not. |
| Baseline hormone lab panel | Estradiol, testosterone, progesterone, thyroid, and PSA for men. How much is covered depends on whether your plan accepts the clinical reason for testing. |
| The pellets themselves | Dose dependent. Women are typically dosed at 2.5 mg, 5 mg or 7.5 mg; men are dosed individually and usually higher. A higher dose costs more. |
| The insertion procedure | A five minute in-office procedure under local anesthesia, placed under the skin of the upper buttock. |
| Number of insertions per year | This is the one that moves the total most. Women need repeat insertions every 3 to 4 months, so roughly three to four per year. Men need them every 4 to 6 months, so two to three per year. |
| Follow-up labs | Mid-cycle or post-insertion testing to check whether the dose landed where it should, repeated through the year. |
| Optional additions | Body composition scans, thyroid treatment, nutritional counseling, each priced separately. |
So the useful question is not what a pellet insertion costs. It is what the first twelve months cost, including labs and the two to four insertions you will actually need. Ask for that figure in writing. Any clinic that will not put a twelve month estimate on paper is not being straight with you.
There is one FDA-approved implantable hormone pellet in the United States: a testosterone pellet, approved for men with diagnosed hypogonadism from testicular failure or a pituitary or hypothalamic cause, and for carefully selected males with delayed puberty. If you are a man with documented low testosterone and a diagnosis on file, there is a route where coverage is at least a conversation.
For women, there is no FDA-approved implantable estradiol pellet available in the United States. None. Every estrogen pellet in use here is compounded, meaning prepared by a compounding pharmacy rather than manufactured as an approved drug product. Payers treat them accordingly: Aetna’s medical policy, reviewed in July 2026, classifies implantable estradiol pellets as experimental, investigational or unproven, on the stated grounds that they produce unpredictable and fluctuating serum estrogen concentrations. Other payers take similar positions.
That is the real answer to "does insurance cover pellets". For women, almost certainly not, and the reason is not a paperwork problem you can appeal your way around. It is the regulatory status of the product. Budget for the therapy as an out-of-pocket cost, and ask separately whether the consultation and the lab work can be billed to your plan, because sometimes they can even when the pellets cannot.
If you are deciding how to spend several thousand dollars a year, you should know that the major specialty bodies do not endorse compounded pellets as a first choice.
The American College of Obstetricians and Gynecologists published a Clinical Consensus on compounded bioidentical menopausal hormone therapy in November 2023 and reaffirmed it in 2026. It is endorsed by the American Society for Reproductive Medicine. Its position, in summary: compounding pharmacies use the word bioidentical as a marketing term implying these preparations are natural and therefore safer and more effective than FDA-approved options, and the evidence for those marketing claims "is lacking". ACOG advises that compounded preparations should not be routinely prescribed where FDA-approved formulations exist, and that patients who still want them should be told plainly that they are not FDA approved and what the compounding-specific risks are. The Endocrine Society has taken a comparable position.
This is not a reason nobody should ever use pellets. People do use them, some find the convenience of a procedure every few months genuinely better than remembering a daily dose, and physicians prescribe them after weighing an individual case. It is a reason to go in with accurate expectations rather than the version on a brochure, and to be sceptical of any clinic that tells you compounded pellets are safer or more effective than approved products. That specific claim is the one ACOG names as unsupported.
The most common misunderstanding in this whole area is the belief that you have to go compounded to get bioidentical hormones. You do not. Several FDA-approved products are molecularly identical to human hormones.
One current development worth knowing if safety is driving your thinking: in November 2025 the FDA announced it would remove the boxed warning statements on cardiovascular disease, breast cancer and dementia from systemic menopausal hormone therapy labels, with the change taking effect in February 2026. That relabeling applies to approved products. Compounded pellets were never part of that review, because they were never FDA approved in the first place.
Our longer piece on bioidentical versus synthetic hormone replacement goes through the differences in detail. For men specifically, TRT costs and low testosterone treatment cover the options and what each involves.
That last question is the one that separates a clinic doing medicine from a clinic selling a product. A physician who has already raised the approved options unprompted is giving you the conversation ACOG says you are owed.
Hormone therapy here is managed by board-certified internal medicine physicians, which matters more than the delivery method. Every plan starts with lab work through our on-site laboratory and a medical evaluation, because treating symptoms without measuring levels is how people end up on a therapy they never needed.
Because we are a primary care practice rather than a hormone clinic, we can prescribe FDA-approved formulations or pellets, and the honest recommendation sometimes is neither. Fatigue, low libido, weight change and brain fog are also how thyroid disease, anaemia, sleep apnoea, depression and iron deficiency present, and all of those are cheaper to find and treat than hormone therapy. That work sits inside women's health, men's health and preventive medicine.
Hormone evaluation and therapy are available at all three offices: Glendale, Burbank and La Cañada, serving patients across Los Angeles County including Pasadena, Toluca Lake and the surrounding foothill communities.
Need Help? Find Answers Here
If you want a figure you can plan around, the route to it is an evaluation and a lab panel, after which the cost of your actual plan can be quoted properly. Contact our office to arrange a hormone consultation in Glendale, Burbank or La Cañada.
This article is general health information, not medical advice, and reading it does not create a physician-patient relationship. Compounded bioidentical hormone preparations, including compounded hormone pellets, are not approved by the FDA, and their safety and effectiveness have not been established by FDA review. Individual results vary. Any hormone therapy should be started, changed or stopped only under the supervision of a qualified clinician after appropriate evaluation.

CDC advises a travel health appointment 4 to 6 weeks before departure. What a travel consultation covers, which vaccines take time, and what to bring.

A physician-reviewed look at semaglutide and tirzepatide: how each one works, what the head-to-head trial measured, and what both labels warn about.
Mon - Fri: 8:00 AM to 12:00 PM, 1:00 PM to 5:00 PM
Sat - Sun: Closed
© 2026 Elevate Health Group. All rights reserved.
Designed & Developed by The Gud Agency